Increased stability of airflow following botulinum toxin injection
- PMID: 10443837
- DOI: 10.1097/00005537-199908000-00021
Increased stability of airflow following botulinum toxin injection
Abstract
Objectives: The purpose of this study was to determine whether stability of airflow, as well as mean airflow, increased following botulinum toxin injection to laryngeal and extralaryngeal muscles in persons with spasmodic dysphonia (SD), some with associated vocal tremor (VT).
Study design: Aerodynamic data were collected from five subjects before and at 2, 4, and 8 weeks after they received treatment by each of two different arms in an injection protocol in a crossover study. One arm of the protocol involved treatment of the thyroarytenoid muscles only. The other arm involved treatment of both the thyroarytenoid muscles and the strap muscles.
Methods: Measures of mean airflow and coefficient of variation (COV) of airflow during phonation were obtained. A decrease in the COV of airflow would indicate increased stability of phonatory airflow.
Results: Before treatment, all subjects with SD/VT exhibited mean airflows that were similar to controls. The COV of airflow ranged from normal to substantially elevated. Following botulinum injection, mean airflow characteristically increased and COV of airflow decreased.
Conclusions: This finding suggests there is a change in the type, as well as the level, of activity in the muscles of speech production following botulinum toxin injection. The increase in airflow stability identified could be due to increased stability of the laryngeal system and possibly of the respiratory system as well.
Similar articles
-
Botulinum toxin injection and airflow stability in spasmodic dysphonia.Otolaryngol Head Neck Surg. 2006 Mar;134(3):419-23. doi: 10.1016/j.otohns.2005.10.028. Otolaryngol Head Neck Surg. 2006. PMID: 16500438
-
Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.J Med Assoc Thai. 2006 Dec;89(12):2077-80. J Med Assoc Thai. 2006. PMID: 17214059
-
Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.Laryngoscope. 1991 Jun;101(6 Pt 1):630-4. doi: 10.1288/00005537-199106000-00010. Laryngoscope. 1991. PMID: 2041443 Clinical Trial.
-
[Spasmodic dysphonia. Investigation and therapeutic methods].Rev Neurol (Paris). 1992;148(3):180-3. Rev Neurol (Paris). 1992. PMID: 1604131 Review. French.
-
[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Wien Klin Wochenschr. 2001. PMID: 15506048 Review. German.
Cited by
-
An update on the use of botulinum toxin therapy in Parkinson's disease.Curr Neurol Neurosci Rep. 2015 Jan;15(1):511. doi: 10.1007/s11910-014-0511-3. Curr Neurol Neurosci Rep. 2015. PMID: 25407133 Review.
-
Current and future medical treatment in primary dystonia.Ther Adv Neurol Disord. 2012 Jul;5(4):221-40. doi: 10.1177/1756285612447261. Ther Adv Neurol Disord. 2012. PMID: 22783371 Free PMC article.
-
Botulinum toxin injections for the treatment of spasmodic dysphonia.Cochrane Database Syst Rev. 2004;2004(3):CD004327. doi: 10.1002/14651858.CD004327.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266530 Free PMC article.
-
Discriminating simulated vocal tremor source using amplitude modulation spectra.J Voice. 2015 Mar;29(2):140-7. doi: 10.1016/j.jvoice.2014.07.020. Epub 2014 Dec 19. J Voice. 2015. PMID: 25532813 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical